Solid Report From Goldman Sachs, Revenue Falls Short At BofA; Eli Lilly In Spotlight Wednesday

Investors have been discouraged by stumbles from Eli Lilly and Johnson & Johnson in the coronavirus fight, but market participants seem to be taking some cheer from decent bank earnings, including a much better than expected report from Goldman Sachs.